GRB2 and head and neck squamous cell carcinoma: Furthermore, our data suggest that the cell adhesion receptor β1 integrin contributes to resistance to the PI3Kα inhibitor Alpelisib in a subset of HNSCC models via the adaptor protein Grb2.